Cargando…
Tolvaptan Efficiently Reduces Intracellular Fluid: Working Toward a Potential Treatment Option for Cellular Edema
OBJECTIVE: Tolvaptan is a class of diuretics that reduce body water through aquaresis. One of the most prominent characteristics of these agents is that worsening of the renal function is less likely to occur. We investigated the underlying mechanism concerning the change in the intracellular fluid...
Autores principales: | Kawabata, Hiroaki, Iwatani, Hirotsugu, Yamamichi, Yuko, Shirahase, Keiko, Nagai, Naoko, Isaka, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443539/ https://www.ncbi.nlm.nih.gov/pubmed/30449775 http://dx.doi.org/10.2169/internalmedicine.0993-18 |
Ejemplares similares
-
Tolvaptan Reduces Extracellular Fluid per Amount of Body Fluid Reduction Less Markedly than Conventional Diuretics
por: Iwatani, Hirotsugu, et al.
Publicado: (2022) -
Efficacy and safety of tolvaptan for refractory fluid collection and edema in the terminal cancer patients
por: Tsuzuki, Norimasa, et al.
Publicado: (2023) -
Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid Retention
por: Masuda, Takahiro, et al.
Publicado: (2016) -
Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020) -
Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients
por: Imai, Shunichi, et al.
Publicado: (2018)